Soleno Therapeutics, Inc. (SLNO) Insider Trading

Over the last 3 months, SLNO insiders made 0 open-market buys and 6 sales, a net sale of -$429K (SEC Form 4). Over the last 6 months, 211 institutions increased and 136 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
6
Net (3m)
-$429.3K
Insider trades by month Buys Sells
Jan
Mar
Apr
Jun
Jul
Mar
Context3-month price +34.5%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Mar 31, 2026Manning Meredithofficer: Chief Commercial OfficerSell2,100$31.04
Mar 31, 2026Manning Meredithofficer: Chief Commercial OfficerSell558$31.72
Mar 31, 2026Huang Michael F.officer: Sr. VP of Clinical DevelopmentSell488$31.72
Mar 31, 2026Manning Meredithofficer: Chief Commercial OfficerSell4,864$30.04
Mar 31, 2026Huang Michael F.officer: Sr. VP of Clinical DevelopmentSell1,838$31.04
Mar 31, 2026Huang Michael F.officer: Sr. VP of Clinical DevelopmentSell4,256$30.04
Mar 4, 2026Fulk Jenniferofficer: CHIEF FINANCIAL OFFICEROption67,660$39.06
Mar 4, 2026Fulk Jenniferofficer: CHIEF FINANCIAL OFFICERGrant39,200—
Jan 23, 2026Anish Bhatnagardirector, officer: CHIEF EXECUTIVE OFFICERGrant114,200—
Jan 23, 2026Yen Kristenofficer: SEE REMARKSGrant11,900$43.65
Jan 23, 2026Huang Michael F.officer: Sr. VP of Clinical DevelopmentGrant11,900$43.65
Jan 23, 2026Joshi Manherofficer: Chief Development OfficerGrant4,100—
Jan 23, 2026Norrett Kevinofficer: Chief Business OfficerGrant4,000$43.65
Jan 23, 2026Yen Kristenofficer: SEE REMARKSGrant10,400—
Jan 23, 2026Joshi Manherofficer: Chief Development OfficerGrant4,700$43.65
Jan 23, 2026Huang Michael F.officer: Sr. VP of Clinical DevelopmentGrant10,400—
Jan 23, 2026Anish Bhatnagardirector, officer: CHIEF EXECUTIVE OFFICERGrant131,400$43.65
Jan 23, 2026Hirano Patricia Cofficer: SEE REMARKSGrant11,900$43.65
Jan 23, 2026Mackaness James Hofficer: CHIEF FINANCIAL OFFICERGrant32,800$43.65
Jan 23, 2026Mackaness James Hofficer: CHIEF FINANCIAL OFFICERGrant28,600—
Jan 23, 2026Manning Meredithofficer: Chief Commercial OfficerGrant32,800$43.65
Jan 23, 2026Hirano Patricia Cofficer: SEE REMARKSGrant10,400—
Jan 23, 2026Norrett Kevinofficer: Chief Business OfficerGrant3,500—
Jan 23, 2026Manning Meredithofficer: Chief Commercial OfficerGrant28,600—
Dec 17, 2025Huang Michael F.officer: Sr. VP of Clinical DevelopmentTax812$49.95
Dec 17, 2025Anish Bhatnagardirector, officer: CHIEF EXECUTIVE OFFICERTax7,620$49.95
Dec 17, 2025Manning Meredithofficer: Chief Commercial OfficerTax1,922$49.95
Dec 17, 2025Hirano Patricia Cofficer: SEE REMARKSTax904$49.95
Dec 17, 2025Mackaness James Hofficer: CHIEF FINANCIAL OFFICERTax2,013$49.95
Dec 17, 2025Yen Kristenofficer: SEE REMARKSTax904$49.95

Source: SLNO SEC Form 4 filings, latest Mar 31, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their SLNO positions over the last 6 months (SEC Form 13F).

Increased
211
New positions
100
Reduced
136
Sold out
113
Largest moves
InstitutionActionSharesFiled
FMR LLCIncreased8.1MFeb 17, 2026
JANUS HENDERSON GROUP PLCIncreased7.2MFeb 17, 2026
JANUS HENDERSON GROUP PLCReduced7.1MMay 18, 2026
FMR LLCReduced5.8MMay 15, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased4.4MMay 15, 2026
BLACKROCK, INC.Increased3.9MFeb 12, 2026
BLACKROCK, INC.Reduced3.7MMay 13, 2026
WELLINGTON MANAGEMENT GROUP LLPIncreased3.3MFeb 17, 2026
PRICE T ROWE ASSOCIATES INC /MD/Reduced3.3MFeb 17, 2026
VANGUARD GROUP INCIncreased3.1MJan 29, 2026
AVORO CAPITAL ADVISORS LLCIncreased2.9MMar 16, 2026
STATE STREET CORPIncreased2.7MMay 15, 2026
STATE STREET CORPIncreased2.6MFeb 13, 2026
AVORO CAPITAL ADVISORS LLCReduced2.3MMay 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2.2MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.

← Back to SLNO overview (price, financials, earnings)